45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
14,374
Insurances with rates
7
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| SUP-83234 | GENERATOR NEUROSTIMULATOR REMEDE PULSE | $550,000 | $550,000 | — | — | 4 |
| RX-104852 | SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION | $187,808 | $187,808 | — | — | 4 |
| 629 | OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH CC | $159,106 | $159,106 | — | — | 4 |
| PX-481332740 | HC Tcat Insj/Rpl Perm Ldls Pm | $139,240 | $139,240 | — | — | 4 |
| 275 | CARDIAC DEFIBRILLATOR IMPLANT WITH CARDIAC CATHETERIZATION AND MCC | $132,692 | $132,692 | — | — | 4 |
| RX-184131 | GIVOSIRAN 189 MG/ML SUBCUTANEOUS SOLUTION | $131,682 | $131,682 | — | — | 4 |
| RX-194930 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION | $124,161 | $124,161 | — | — | 4 |
| RX-201599 | OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23,000 UNIT/23 ML SUBCUT SOLN | $123,846 | $123,846 | — | — | 4 |
| 276 | CARDIAC DEFIBRILLATOR IMPLANT WITH MCC OR CAROTID SINUS NEUROSTIMULATOR | $110,503 | $110,503 | — | — | 4 |
| RX-108956 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $108,657 | $108,657 | — | — | 4 |
| 870 | SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | $106,024 | $106,024 | — | — | 4 |
| 273 | PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITH MCC | $101,522 | $101,522 | — | — | 4 |
| 492 | LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH MCC | $94,148 | $94,148 | — | — | 4 |
| RX-107664 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $92,229 | $92,229 | — | — | 4 |
| 274 | PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITHOUT MCC | $90,477 | $90,477 | — | — | 4 |
| RX-189782 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $87,089 | $87,089 | — | — | 4 |
| 332 | RECTAL RESECTION WITH MCC | $81,589 | $81,589 | — | — | 4 |
| PX-361332490 | HC Cc Acid Insertion Single or Dual | $78,365 | $78,365 | — | — | 4 |
| PX-361332640 | HC Cc Aicd Battery Change Multi Lead | $78,365 | $78,365 | — | — | 4 |
| 321 | PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITH MCC OR 4+ ARTERIES/INTRALUMINAL | $78,345 | $78,345 | — | — | 4 |
| 260 | CARDIAC PACEMAKER REVISION EXCEPT DEVICE REPLACEMENT WITH MCC | $76,899 | $76,899 | — | — | 4 |
| 253 | OTHER VASCULAR PROCEDURES WITH CC | $73,616 | $73,616 | — | — | 4 |
| 326 | STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH MCC | $71,953 | $71,953 | — | — | 4 |
| 323 | CORONARY INTRAVASCULAR LITHOTRIPSY WITH INTRALUMINAL DEVICE WITH MCC | $68,454 | $68,454 | — | — | 4 |
| 957 | OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC | $67,510 | $67,510 | — | — | 4 |
| 827 | MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC | $65,996 | $65,996 | — | — | 4 |
| 799 | SPLENIC PROCEDURES WITH MCC | $64,786 | $64,786 | — | — | 4 |
| 478 | BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC | $64,107 | $64,107 | — | — | 4 |
| 570 | SKIN DEBRIDEMENT WITH MCC | $63,745 | $63,745 | — | — | 4 |
| 329 | MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MCC | $62,007 | $62,007 | — | — | 5 |
| RX-175187 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $61,923 | $61,923 | — | — | 4 |
| 270 | OTHER MAJOR CARDIOVASCULAR PROCEDURES WITH MCC | $61,841 | $61,841 | — | — | 5 |
| 207 | RESPIRATORY SYSTEM DIAGNOSIS WITH VENTILATOR SUPPORT >96 HOURS | $61,262 | $61,262 | — | — | 4 |
| 335 | PERITONEAL ADHESIOLYSIS WITH MCC | $61,238 | $61,238 | — | — | 4 |
| 040 | PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITH MCC | $60,755 | $60,755 | — | — | 6 |
| 474 | AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH MCC | $60,730 | $60,730 | — | — | 4 |
| 483 | MAJOR JOINT OR LIMB REATTACHMENT PROCEDURES OF UPPER EXTREMITIES | $60,468 | $60,468 | — | — | 4 |
| 239 | AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITH MCC | $59,319 | $59,319 | — | — | 4 |
| PX-481936530 | HC Ep Compre Ep Eval Abltj 3d Mapg Tx Svt | $58,703 | $58,703 | — | — | 5 |
| PX-481936540 | HC Ep Compre Ep Eval Abltj 3d Mapg Tx Vt | $58,703 | $58,703 | — | — | 4 |
| PX-481936560 | HC Ep Compre Ep Eval Abltj Atr Fib Pulm Vein Isolation | $58,703 | $58,703 | — | — | 5 |
| 616 | AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH MCC | $57,841 | $57,841 | — | — | 4 |
| 468 | REVISION OF HIP OR KNEE REPLACEMENT WITHOUT CC/MCC | $57,356 | $57,356 | — | — | 4 |
| 516 | OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH CC | $57,201 | $57,201 | — | — | 4 |
| 749 | OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC | $57,190 | $57,190 | — | — | 4 |
| 579 | OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH MCC | $56,624 | $56,624 | — | — | 4 |
| RX-195188 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION | $56,183 | $56,183 | — | — | 4 |
| PX-361332620 | HC Cc Aicd Battery Change Single Lead | $56,147 | $56,147 | — | — | 4 |
| PX-361332630 | HC Cc Aicd Battery Change Dual Lead | $56,147 | $56,147 | — | — | 4 |
| RX-182753 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $55,834 | $55,834 | — | — | 4 |
Showing top 50 of 14,374 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.